Park Pyeongtak
Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
Latest Articles
Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"
From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical
powered by 